Therapeutic applications of microbial secondary metabolites provided the opportunity for the discovery of antibiotics, immunosuppressants, cholesterol lowering and anticancer drugs. Most natural products used in medicine are isolated from plants. The isolation is usually quite a difficult, expensive and non-ecological process. Therefore we focused on microbial sources of enzyme inhibitors. Although many substances were already discovered in the last century, their potential and various modifications are still promising. An interest in enzyme inhibitors is steadily growing due to their potential in the management of metabolic disorders and serious diseases and also due to finding more effective and safer drugs.

Ústav biotechnológie a potravinárstva Fakulta chemickej a potravinárskej technológie Slovenská technická univerzita Radlinského 9 812 37 Bratislava

Microbial hydrolases inhibitors and their therapeutic potential

000      

00000naa a2200000 a 4500

001      

bmc13016679

003      

CZ-PrNML

005      

20130528145534.0

007      

ta

008      

130429s2013 xr a f 000 0slo||

009      

AR

040    __

$a ABA008 $d ABA008 $e AACR2 $b cze

041    0_

$a slo $b eng

044    __

$a xr

100    1_

$a Buchtová, Eva. $7 _AN069240 $u Ústav biotechnológie a potravinárstva, Fakulta chemickej a potravinárskej technológie, Slovenská technická univerzita, Radlinského 9, 812 37 Bratislava

245    10

$a Mikrobiálne produkované inhibítory hydroláz a ich terapeutický potenciál / $c E. Buchtová, M. Šturdíková

246    31

$a Microbial hydrolases inhibitors and their therapeutic potential

520    9_

$a Therapeutic applications of microbial secondary metabolites provided the opportunity for the discovery of antibiotics, immunosuppressants, cholesterol lowering and anticancer drugs. Most natural products used in medicine are isolated from plants. The isolation is usually quite a difficult, expensive and non-ecological process. Therefore we focused on microbial sources of enzyme inhibitors. Although many substances were already discovered in the last century, their potential and various modifications are still promising. An interest in enzyme inhibitors is steadily growing due to their potential in the management of metabolic disorders and serious diseases and also due to finding more effective and safer drugs.

650    12

$a hydrolasy $x antagonisté a inhibitory $x terapeutické užití $7 D006867

650    _2

$a alfa-glukosidasy $x antagonisté a inhibitory $x terapeutické užití $7 D000520

650    _2

$a beta-glukosidasa $x antagonisté a inhibitory $x terapeutické užití $7 D001617

650    _2

$a alfa-amylasy $x antagonisté a inhibitory $x terapeutické užití $7 D000516

650    _2

$a neuraminidasa $x antagonisté a inhibitory $x terapeutické užití $7 D009439

650    _2

$a proteasy $7 D010447

650    _2

$a inhibitory adenosindeaminasy $x aplikace a dávkování $x terapeutické užití $7 D058892

650    12

$a inhibitory enzymů $x terapeutické užití $7 D004791

650    12

$a mikrobiologické jevy $7 D008827

650    12

$a biologické přípravky $x metabolismus $x terapeutické užití $7 D001688

650    _2

$a lidé $7 D006801

700    1_

$a Šturdíková, Mária $7 xx0107051 $u Ústav biotechnológie a potravinárstva, Fakulta chemickej a potravinárskej technológie, Slovenská technická univerzita, Radlinského 9, 812 37 Bratislava

773    0_

$t Chemické listy $x 0009-2770 $g Roč. 107, č. 1 (2013), s. 30-36 $w MED00011010

856    41

$u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/785/785 $y domovská stránka časopisu - plný text volně přístupný

910    __

$a ABA008 $b B 1918 $c 395 $y 3 $z 0

990    __

$a 20130429082755 $b ABA008

991    __

$a 20130528145903 $b ABA008

999    __

$a ok $b bmc $g 979974 $s 815006

BAS    __

$a 3

BMC    __

$a 2013 $b 107 $c 1 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010 $d 30-36

LZP    __

$c NLK137 $d 20130528 $a NLK 2013-23/vt